(Q54346826)

28 May 2018

title

Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma. (English)

1 reference

28 May 2018

1 reference

2

Hidetaka Uramoto

1 reference

28 May 2018

Fumihiro Tanaka

5

object named as

Fumihiro Tanaka

1 reference

28 May 2018

Soichi Oka

1

object named as

Soichi Oka

1 reference

28 May 2018

Hidehiko Shimokawa

3

object named as

Hidehiko Shimokawa

1 reference

28 May 2018

author name string

Sohsuke Yamada

4

1 reference

28 May 2018

publication date

4 June 2014

1 reference

28 May 2018

published in

Oncology

1 reference

28 May 2018

volume

86

1 reference

28 May 2018

issue

5-6

1 reference

28 May 2018

page(s)

263-270

1 reference

28 May 2018

cites work

Cancer statistics, 2010

1 reference

Prognostic factors in non-small cell lung cancer: a decade of progress

21 January 2018

1 reference

A perspective on DNA microarrays in pathology research and practice

21 January 2018

1 reference

Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?

21 January 2018

1 reference

Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma

21 January 2018

1 reference

The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

21 January 2018

1 reference

Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.

21 January 2018

1 reference

Expression of deltaNp73 predicts poor prognosis in lung cancer

21 January 2018

1 reference

The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside

21 January 2018

1 reference

ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis

21 January 2018

1 reference

Regulation of cadherin-mediated adhesion in morphogenesis

21 January 2018

1 reference

GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis

21 January 2018

1 reference

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000360089

1 reference

28 May 2018

1 reference

28 May 2018